Pharmaceutical regulation in the single European market

Medicine and Law

Volumn 17, Issue 3, 1998, Pages 401-427

  Matthews, Duncan ^a,b   Wilson, Caroline ^a  

^a NATIONAL INSTITUTE OF ECONOMIC AND SOCIAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

European community; European Medicines Evaluation Agency; Market authorisation; Medicines; Pharmaceuticals; Regulation

Indexed keywords

THALIDOMIDE;

ARTICLE; AUTHORITY; COST EFFECTIVENESS ANALYSIS; DRUG CONTROL; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; EUROPEAN UNION; HEALTH ECONOMICS; LAW; MARKET; PHARMACY;

EID: 0032462649     PISSN: 07231393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cartwright, A. C. and Matthews, B. R. (1991) "Pharmaceutical Product Licensing Requirements for Europe", Ellis Horwood Limited.
2. Commission of the European Communities (1997a) "Panorama of EU Industry 1997", Brussels: Commission of the European Communities.
3. Commission of the European Communities (1997b) "Impact on Manufacturing Pharmaceutical Products", Single Market Review Sub-series I, Volume 2, Brussels and London: Commission of the European Communities and Kogan Page/Earthscan.
4. CPMP (1994) "Annual Report 1993-94", Brussels: Committee for Proprietary Medicinal Products.
5. Economist Intelligence Unit (1995) ""OTC Pharmaceuticals in the European Union", London: EIU.
6. EMEA (1996) "Second General Report", London: European Agency for the Evaluation of Medicinal Products.
7. EMEA (1997) "EMEA Status Report", April, London: European Agency for the Evaluation of Medicinal Products.
8. Evers, P. (1995) "Pharmaceutical Regulation in Europe", London: Financial Times Management Reports.
9. Hart, P. E. (1992) "The Effects of '1992' on the Pharmaceuticals Industry in Britain and Germany", National Institute of Economic and Social Research Discussion Paper No. 8.
10. Kendall, V. (1993) "Pharmaceuticals in the Single Market: progress and problems", European Trends, London: Economist Intelligence Unit.
11. Kendall, V. (1994) "Scrip's International Harmonisation of Pharmaceutical Registration Report", Richmond: PJB Publications Ltd.
12. Kendall, V. (1995) "Pharmaceuticals in the EU - a new industrial policy", Richmond: PJB Publications Ltd.
13. Majone, G. (1996) "Regulating Europe", London: Routledge.
14. Matthews, D. (1997) "The Evolution of Rules", in Mayes, D. (ed.) The Evolution of the Single European Market, Cheltenham: Edward Elgar, pp. 167-199.
15. Matthews, D. and Mayes, D. G. (1992) "The Effect of '1992' on the Machine Tool Industry in Britain and Germany", National Institute of Economic and Social Research Discussion Paper No. 30.
16. Matthews, D. and Mayes, D. G. (1993) "The Evolution of Rules for a Single European Market in Leasing", National Institute of Economic and Social Research Discussion Paper No. 35.
17. Matthews, D. and Mayes, D. G. (1994) "The Role of Soft Law in the Evolution of Rules for a Single European Market: the Case of Retailing", National Institute of Economic and Social Research Discussion Paper No. 61.
18. Matthews, D. and Pickering, J. F. (1995) "The Role of the Firm in the Evolution of Social Policy Rules: the Case of the UK Construction Industry", National Institute of Economic and Social Research Discussion Paper No. 84.
19. Matthews, D. and Pickering, J. F (1996) "The Role of the Firm in the Evolution of Environmental Rules: the Case of the Water Industry and the Drinking Water Directive", National Institute of Economic and Social Research Discussion Paper No. 92.
20. Matthews, D. and Pickering, J. F. (1997) "The Evolution of the Single European Market in Insurance", National Institute of Economic and Social Research Discussion Paper No. 115.
21. Mossialos, E., Kanavos, P. and Abel-Smith, B. (1993) "Policy Options for Pharmaceutical Research and Development in the European Community", LSE Health, Occasional Papers in Health Policy No. 1, London: London School of Economics.
22. Neal, M. (1995) "Keeping Cures from Patients. The Perverse Effects of Pharmaceutical Regulation", Social Affairs Unit.
23. Pickering, J. F. and Matthews, D. (1997) "Industry, Regulation and the Single European Market", National Institute of Economic and Social Research Discussion Paper No. 110.
24. Scrip Yearbook (1996), London: PJB Publications.
25. Thompson, R. (1994) "The Single Market for Pharmaceuticals", London: Butterworths.
26. Woolcock, S. (1994) "The Single European Market: Centralization or Competition among National Rules?", London: Royal Institute of International Affairs.